HOW TABLET DECREASES BLOOD LOSS DURING UTERUS SURGERIES
Phase 4
- Conditions
- Health Condition 1: null- Women with symptomatic myomas posted for total abdominal hysterectomy witha. Age between 36-55years, b.With size of uterus between 10-24wk,c. Preoperative haemoglobin between 10-13gm%.
- Registration Number
- CTRI/2014/04/004560
- Lead Sponsor
- FATHER MULLER MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Women with symptomatic myomas posted for total abdominal hysterectomy with
a. Age between 36-55years,
b.With size of uterus between 10-24wk,
c. Preoperative haemoglobin between 10-13gm%.
Exclusion Criteria
•Women with heart disease, severe hypertension, haematological disorders, glaucoma, bronchial asthma, liver disease, pelvic endometriosis, adnexal mass
•women who had undergone previous myomectomy
•women who received GnRH analogues
•women who were allergic to prostaglandins
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome is to measure the hysterectomy-related blood loss during operation after administering sublingual misoprostolTimepoint: primary outcome is to measure the hysterectomy-related blood loss during operation.
- Secondary Outcome Measures
Name Time Method . Secondary outcome measures will be the drop in hemoglobin level 24 hours after the operation and the need of blood transfusion.Timepoint: 2 years